APBN MOC Part III Pilot Project

The following Continuum articles have been selected by the American Board of Psychiatry and Neurology (ABPN) for inclusion in the ABPN MOC Part III Pilot Project. The American Academy of Neurology has made these articles open to all neurologists participating in the pilot project, which runs through 2021. For questions regarding the pilot project, please visit the APBN's website, or contact the ABPN directly.

Contains: 5 Items
2018 June Volume 24, 804-827
Mood Disorders

Rakofsky, Jeffrey; Rapaport, Mark

Audio Interview
PURPOSE OF REVIEW This article discusses the prevalence of the major mood disorders (major depressive disorder and bipolar disorder) in the community and within neurologic settings, articulates the steps taken to make a diagnosis of major depressive disorder or bipolar disorder, and reviews old and newer treatment options with proven efficacy for the treatment of these two conditions. RECENT FINDINGS New medications are available as treatment options for major depressive disorder and bipolar disorder, such as intranasal and IV ketamine, and somatic treatments, such as deep brain stimulation and vagal nerve stimulators, are being used to target treatment-resistant depression. SUMMARY Mood disorders are c...
2018 February Volume 24, 96-129
Neurocutaneous Disorders

Rosser, Tena

Audio Interview
PURPOSE OF REVIEW This article presents an up-to-date summary of the genetic etiology, diagnostic criteria, clinical features, and current management recommendations for the most common neurocutaneous disorders encountered in clinical adult and pediatric neurology practices. RECENT FINDINGS The phakomatoses are a phenotypically and genetically diverse group of multisystem disorders that primarily affect the skin and central nervous system. A greater understanding of the genetic and biological underpinnings of numerous neurocutaneous disorders has led to better clinical characterization, more refined diagnostic criteria, and improved treatments in neurofibromatosis type 1, Legius syndrome, neurofibromatosis...
2018 February Volume 24, 18-36
Genetic Diagnostics for Neurologists

Silveira-Moriyama, Laura; Paciorkowski, Alex R.

Audio Interview
PURPOSE OF REVIEW This article puts advances in the field of neurogenetics into context and provides a quick review of the broad concepts necessary for current practice in neurology. RECENT FINDINGS The exponential growth of genetic testing is due to its increased speed and decreasing cost, and it is now a routine part of the clinical care for a number of neurologic patients. In addition, phenotypic pleiotropy (mutations in the same gene causing very disparate phenotypes) and genetic heterogeneity (the same clinical phenotype resulting from mutations in different genes) are now known to exist in a number of conditions, adding an additional layer of complexity for genetic testing in these disorders. SUMMAR...
2017 August Volume 23, 1005-1016
Restless Legs Syndrome and Sleep-Related Movement Disorders

Trotti, Lynn Marie

Audio Interview
Purpose of Review: This article provides an update on six sleep-related movement disorders: restless legs syndrome (RLS), periodic limb movement disorder, sleep-related leg cramps, bruxism, rhythmic movement disorder, and propriospinal myoclonus, with an emphasis on RLS.
2016 August Volume 22, 1064-1085
Treating the Motor Symptoms of Parkinson Disease

Morgan, John C.; Fox, Susan H.

Audio Interview
Purpose of Review: After a patient is diagnosed with Parkinson disease (PD), there are many therapeutic options available. This article provides examples of prototypical patients encountered in clinical practice and illustrates the various pharmacologic and nonpharmacologic treatment options for the motor symptoms of PD.